Therapeutic Potential of Hammerhead Ribozymes in the Treatment of Hyper-Proliferative Diseases
Journal:
Current Pharmaceutical Biotechnology
Volume:
5
Page:
369-386
Author(s):
G. Grassi, P. Dawson, G. Guarnieri, R. Kandolf and M. Grassi
Corticotropin Releasing Factor (CRF) Peptide Family and their Receptors: Divergent Actions Influencing Human Physiology
Journal:
Current Genomics
Volume:
5
Page:
473-481
Author(s):
E. Karteris, H. S. Randeva and E. W. Hillhouse
Membrane Disrupting Lytic Peptides for Cancer Treatments
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2299-2310
Author(s):
Carola Leuschner and William Hansel
A Review on the Molecular Mechanisms Involved in the Placental Barrier for Drugs
Journal:
Current Drug Delivery
Volume:
1
Page:
275-289
Author(s):
Jose J.G. Marin, Oscar Briz and Maria A. Serrano
Induction of Tumour Cell Senescence: A New Strategy in Anticancer Treatment
Journal:
Medicinal Chemistry Reviews - Online (Discontinued)
Volume:
1
Page:
369-379
Author(s):
Xianghong Wang and Yong-Chuan Wong
ELISA-based Protein Arrays: Multiplexed Sandwich Immunoassays
Journal:
Current Proteomics
Volume:
1
Page:
199-210
Author(s):
Ruo-Pan Huang, Ying Lin, Li-Pai Chen, Weimin Yang and Ruochun Huang
Meet the Editorial Board
Journal:
Combinatorial Chemistry & High Throughput Screening
Volume:
7
Page:
394-396
Author(s):
David Robinson Goodlett
Microfilament Actin Remodeling as a Potential Target for Cancer Drug Development
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
345-354
Author(s):
Jian Yu Rao and Ning Li
The Akt Pathway: Molecular Targets for Anti-Cancer Drug Development
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
235-256
Author(s):
Constantine S. Mitsiades, Nicholas Mitsiades and Michael Koutsilieris
Targeting Translation for Treatment of Cancer - A Novel Role for IRES?
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
299-311
Author(s):
Martin Holcik